SCHEMBL17558249

SCHEMBL17558249

Cc1nc(CC(C)O)c([N+](=O)[O-])[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 6/20 0.43
MDM2 Q00987 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
LMNA P02545 1/20 0.35
GFER P55789 1/20 0.32
RAB9A P51151 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
NOS2 P35228 1/20 0.30
FBP1 P09467 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369094 0.84 ALDH1A1 (0.48) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL27890971 0.83 ALDH1A1 (0.47) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL27722636 0.83 ALDH1A1 (0.60) ALDH1A1GAAMAPTMDM2SMN1; SMN2
Hydrochloric Acid SCHEMBL28933338 0.81 ALDH1A1 (0.59) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL8663859 0.79 MAPT (0.47) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL29054328 0.78 ALDH1A1 (0.43) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL7801786 0.77 ALDH1A1 (0.45) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL3469591 0.76 MAPT (0.49) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL4413021 0.75 MAPT (0.44) ALDH1A1GAAMAPTMDM2SMN1; SMN2
SCHEMBL3465555 0.74 ALDH1A1 (0.47) ALDH1A1GAAMAPTMDM2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4236918-A1 METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING TRICHOMONIASIS AND USES THEREOF Lupin Inc. (US) 2023-09-06 EP disclosed
WO-2021011622-A1 SECNIDAZOLE SOFT GELATIN CAPSULE AND METHODS AND USES THEREOF Lupin Inc. (US) 2021-01-21 WO disclosed
WO-2016037131-A1 SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS SYMBIOMIX THERAPEUTICS, LLC (US) 2016-03-10 WO disclosed